Abstract 6349: A subgroup of potent CB002 xanthine derivatives define a novel class of anti-cancer drugs that restore the p53 pathway in tumors with mutated p53 and target an S-phase checkpoint - KIVIRID

Abstract 6349: A subgroup of potent CB002 xanthine derivatives define a novel class of anti-cancer drugs that restore the p53 pathway in tumors with mutated p53 and target an S-phase checkpoint

Authors: Liz Janice Hernandez Borrero, David T. Dicker, Wafik S. El-Deiry

Published: 2020-09-04

DOI: 10.1158/1538-7445.am2020-6349

Source: Full article

Abstract

Abstract